New purine derivatives.
D000614:Aminocaproates; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D000917:Antibody Formation / Q000187:drug effects; D000921:Antibody-Producing Cells / Q000187:drug effects; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002490:Central Nervous System / Q000187:drug effects; D003877:Dermatitis, Contact / Q000188:drug therapy; D004912:Erythrocytes / Q000187:drug effects; D004983:Ethanolamines; D006460:Hemolysin Proteins; D007165:Immunosuppression Therapy / Q000187:drug effects; D007962:Leukocytes / Q000187:drug effects; D015122:Mercaptopurine; D051379:Mice; D011480:Protease Inhibitors; D011687:Purines / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D016038:Skin Transplantation; D014181:Transplantation Immunology / Q000187:drug effects*; D014184:Transplantation, Homologous; D062367:ortho-Aminobenzoates
D000614:Aminocaproates; D000893:Anti-Inflammatory Agents; D004983:Ethanolamines; D006460:Hemolysin Proteins; D011480:Protease Inhibitors; D011687:Purines; D062367:ortho-Aminobenzoates; D015122:Mercaptopurine